(Q35105771)

6 August 2017

1 reference

title

Antipsychotic drug-induced movement disorders (English)

1 reference

6 August 2017

Antipsychotic Drug-Induced Movement Disorders (English)

1 reference

https://api.crossref.org/works/10.1017/S0317167100003309

23 December 2023

1 reference

https://api.crossref.org/works/10.1017/S0317167100003309

23 December 2023

author name string

Pierre J. Blanchet

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12691483

23 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12691483

23 December 2023

publication date

1 March 2003

1 reference

full work available at URL

6 August 2017

https://www.cambridge.org/core/services/aop-cambridge-core/content/view/25A7C31F9040AC5D6FA5B224DE6A585D/S0317167100003309a.pdf/div-class-title-antipsychotic-drug-induced-movement-disorders-div.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12691483

https://www.cambridge.org/core/services/aop-cambridge-core/content/view/S0317167100003309

23 December 2023

1 reference

https://api.crossref.org/works/10.1017/S0317167100003309

Canadian Journal of Neurological Sciences

23 December 2023

published in

1 reference

6 August 2017

volume

30 Suppl 1

1 reference

6 August 2017

page(s)

S101-7

1 reference

Markers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia.

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003309

Melatonin treatment for tardive dyskinesia: a double-blind, placebo-controlled, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003309

21 January 2018

Drug-induced dystonia

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003309

The treatment of tardive dyskinesia--a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003309

Carvedilol attenuates neuroleptic-induced orofacial dyskinesia: possible antioxidant mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003309

Managing antipsychotic-induced acute and tardive dystonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003309

Treatment of tardive dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003309

The natural history of tardive dystonia. A long-term follow-up study of 107 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003309

Tardive dystonia in a psychiatric hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003309

Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003309

The prevalence of tardive dyskinesia in neuroleptic-treated diabetics. A controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003309

Prevalence of abnormal involuntary movements ("spontaneous dyskinesias") in the normal elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003309

Prevalence of spontaneous dyskinesia in schizophrenic and non-schizophrenic psychiatric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003309

Pallidal and thalamic neurostimulation in severe tardive dystonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003309

Pallidotomy for tardive dyskinesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003309

Provocative tests with psychostimulant drugs in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003309

The use of psychostimulants in general psychiatry. A reconsideration

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003309

Frozen section in pituitary surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003309

Vitamin B(6) in the treatment of tardive dyskinesia: a double-blind, placebo-controlled, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003309

Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003309

Nigral dysfunction in drug-induced parkinsonism: an 18F-dopa PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003309

Long-term effects of tetrabenazine in hyperkinetic movement disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003309

Prevalence of the rabbit syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003309

A controlled trial of amantadine hydrochloride and neuroleptics in the treatment of tardive dyskinesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003309

Clinical Characteristics and Predisposing Factors in Acute Drug-Induced Akathisia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003309

Genetic polymorphisms for drug metabolism (CYP2D6) and tardive dyskinesia in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003309

Pharmacologic studies of tardive dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003309

7 January 2021

Asymmetry in clinical features of drug-induced parkinsonism

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003309

7 January 2021

Amantadine versus biperiden: a double-blind study of treatment efficacy in neuroleptic extrapyramidal movement disorders

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003309

7 January 2021

Acute extrapyramidal side effects: Serum levels of neuroleptics and anticholinergics

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003309

7 January 2021

The course of tardive dyskinesia and parkinsonism in psychiatric inpatients: 14-year follow-up

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003309

7 January 2021

Neuropathological investigation of 28 brains from patients with dyskinesia

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003309

7 January 2021

Induction of reactive oxygen species in neurons by haloperidol.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003309

7 January 2021

Effects of dopamine agonists, catecholamine depletors, and cholinergic and GABAergic drugs on acute dyskinesias in squirrel monkeys

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003309

7 January 2021

The torsion dystonias: Literature review and genetic and clinical studies

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003309

7 January 2021

Bilateral posteroventral pallidotomy for severe antipsychotic induced tardive dyskinesia and dystonia

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003309

7 January 2021

Acute dystonia during fixed-dose neuroleptic treatment

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003309

7 January 2021

Spontaneous involuntary disorders of movement: their prevalence, severity, and distribution in chronic schizophrenics with and without treatment with neuroleptics

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003309

7 January 2021

https://api.crossref.org/works/10.1017%2FS0317167100003309

1 reference

7 January 2021

Drug-induced parkinsonism in the elderly

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003309

7 January 2021

The prevalence of tardive dystonia, tardive dyskinesia, parkinsonism and akathisia The Curaçao Extrapyramidal Syndromes Study: I.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003309

7 January 2021

Expression of glutamic acid decarboxylase mRNA in striatum and pallidum in an animal model of tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003309

7 January 2021

A survey of drug-induced extrapyramidal reactions

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100003309

7 January 2021

Incidence and correlates of acute extrapyramidal symptoms in first episode of schizophrenia

series ordinal

23

1 reference

https://api.crossref.org/works/10.1017/S0317167100003309

23 December 2023

Identifiers

1 reference

6 August 2017

1 reference